Peter C.
- Country
- Germany
- Department
- N/A
Research Overview
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- Efficacy and Safety Evaluation of Subcutaneous Selatogrel in Preventing Recurrent Acute Myocardial Infarction in Post-AMI Patients
- A Phase 3, Randomized, Double-Blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, After a Recent Acute Coronary Syndrome
Data & Insights
Has run more than one trial at 320 of 794 partner sites.
Specializations
Cardiovascular Disease Management
This investigator specializes in treating patients with acute coronary syndrome and myocardial infarction, with particular emphasis on preventive interventions and acute care strategies.
- Post-heart attack cardiovascular event prevention
- Acute myocardial infarction treatment
- Emergency cardiac care protocols
Their research extends to innovative therapeutic approaches for reducing recurrent cardiac events in high-risk patients.
Stroke Prevention
The investigator focuses on preventing stroke and systemic embolism in patients with atrial fibrillation, exploring advanced therapeutic options for at-risk populations.
- Atrial fibrillation management
- Anticoagulation therapy
- Stroke risk reduction strategies
Their work encompasses comparative analyses of anticoagulation treatments for optimal stroke prevention outcomes.
Emergency Cardiac Care
The investigator studies emergency interventions for acute cardiac events, with particular attention to self-administered treatments for patients experiencing symptoms of acute myocardial infarction.
- Emergency cardiac intervention protocols
- Patient self-administration strategies
- Rapid response treatments
Their research includes innovative approaches to emergency cardiac care delivery and patient empowerment in acute situations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.